N-(3-Chloro-2-methylphenyl)-2-((4-phenyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide

Catalog No. :
ACPQME613
CAS No. :
338425-15-3
Molecular Formula :
C22H18ClN5OS
Molecular Weight :
435.94

IUPAC Name:N-(3-chloro-2-methylphenyl)-2-((4-phenyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide

N-(3-Chloro-2-methylphenyl)-2-((4-phenyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$272.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-Chloro-2-methylphenyl)-2-((4-phenyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide
IUPAC NameN-(3-chloro-2-methylphenyl)-2-((4-phenyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide
Molecular FormulaC22H18ClN5OS
Molecular Weight435.94
SMILESO=C(NC1=CC=CC(Cl)=C1C)CSC2=NN=C(C3=CC=NC=C3)N2C4=CC=CC=C4
InChI KeySMGSYKAWHJRJJN-UHFFFAOYSA-N
SynonymN-(3-chloro-2-methylphenyl)-2-[(4-phenyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]acetamide;N-(3-Chloro-2-methylphenyl)-2-((4-phenyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide;Acetamide, N-(3-chloro-2-methylphenyl)-2-[[4-phenyl-5-(4-pyridinyl)-4H-1,2,4-triazol-3-yl]thio]-
CAS No.338425-15-3

Synthetic Route by SureRoute

1. ACPQME613 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBTWK016 route compound structure diagram
    ACBTWK01687-60-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPQME613 route product structure diagram
    ACPQME613338425-15-3
Inquiry

2. ACPQME613 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPQME613 route product structure diagram
    ACPQME613338425-15-3
Inquiry

Comments (0)